Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical ...

Biomedical and Humanetics Corporation announced that Humanetics has selected Lifecore to provide a range of CDMO services to ...

Any company looking to work with a CDMO should begin by defining its own product’s development requirements. For example, a ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

Founded in 2019 as a New Jersey Innovation Institute, the cell therapy contract development and manufacturing organization ...

Industry Recognizes BIOVECTRA’s Excellence in Microbial Fermentation, Recombinant Protein Production, and Aseptic Fill-Finish ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Nandini Piramal says the CDMO business, which contributed 58% of revenues in FY24, aspires to grow as a $1.2 billion business with a 25% EBITDA margin by 2030 ...

ENCell inks an MOU with CRC to enhance collaboration in the field of cell and gene therapy (CGT), thus expanding its market ...

Humanetics Corporation, a clinical-stage pharmaceutical company, has selected Lifecore Biomedical, a fully integrated CDMO, ...